What Greenwich Lifesciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 13 |
| Sells | 0 | 0 |
| Total trades | 2 | 13 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,200 | 40,800 |
| Disposed | 0 | 0 |
| Net activity | +2,200 | +40,800 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO | Jul 29 | Open-market buy · P | +700 | $13.10 | +$9.17K | 5,611,402 |
| Patel Snehal | CEO and CFO | Jul 28 | Open-market buy · P | +1,500 | $13.59 | +$20.4K | 5,610,702 |
| Patel Snehal | CEO and CFO | Jul 27 | Open-market buy · P | +1,500 | $13.62 | +$20.4K | 5,609,202 |
| Patel Snehal | CEO and CFO | Jul 24 | Open-market buy · P | +1,100 | $12.88 | +$14.2K | 5,607,702 |
| Patel Snehal | CEO and CFO | Jul 23 | Open-market buy · P | +2,500 | $13.14 | +$32.9K | 5,606,602 |
| Patel Snehal | CEO and CFO | Jan 13 | Open-market buy · P | +1,800 | $29.83 | +$53.7K | 5,604,102 |
| Patel Snehal | CEO and CFO | Jan 12 | Open-market buy · P | +2,900 | $27.54 | +$79.9K | 5,602,302 |
| Patel Snehal | CEO and CFO | Dec 31 | Open-market buy · P | +4,300 | $21.36 | +$91.8K | 5,599,402 |
| Patel Snehal | CEO and CFO | Dec 30 | Open-market buy · P | +2,900 | $21.73 | +$63K | 5,595,102 |
| Patel Snehal | CEO and CFO | Dec 18 | Open-market buy · P | +4,100 | $12.62 | +$51.7K | 5,592,202 |
| Patel Snehal | CEO and CFO | Nov 25 | Open-market buy · P | +4,600 | $8.37 | +$38.5K | 5,588,102 |
| Patel Snehal | CEO and CFO | Nov 07 | Open-market buy · P | +10,600 | $8.43 | +$89.4K | 5,583,502 |
| Patel Snehal | CEO and CFO | Oct 31 | Open-market buy · P | +2,300 | $9.26 | +$21.3K | 5,572,902 |
| Patel Snehal | CEO and CFO | Apr 25 | Open-market buy · P | +3,600 | $9.88 | +$35.6K | 5,570,602 |
| Patel Snehal | CEO and CFO | Apr 17 | Open-market buy · P | +5,400 | $8.98 | +$48.5K | 5,567,002 |
| Patel Snehal | CEO and CFO | Apr 07 | Open-market buy · P | +3,600 | $9.10 | +$32.8K | 5,561,602 |
| Patel Snehal | CEO and CFO | Apr 04 | Open-market buy · P | +5,500 | $8.73 | +$48K | 5,558,002 |
| Patel Snehal | CEO and CFO | Jan 10 | Open-market buy · P | +2,500 | $12.51 | +$31.3K | 5,552,502 |
| Patel Snehal | CEO and CFO | Jan 07 | Open-market buy · P | +1,800 | $13.75 | +$24.8K | 5,550,002 |
| Patel Snehal | CEO and CFO | Jan 06 | Open-market buy · P | +1,100 | $13.31 | +$14.6K | 5,548,202 |
Loading...